Liver failure unmasks celiac disease in a child

被引:10
|
作者
Al-Hussaini, Abdulrahman [1 ]
Basheer, Amna [1 ]
Czaja, Albert J. [2 ]
机构
[1] Childrens Hosp, Div Pediat Gastroenterol, Riyadh, Saudi Arabia
[2] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA
关键词
Sclerosing cholangitis; Cirrhosis; Gluten enteropathy; Gluten free diet; GLUTEN-FREE DIET; PRIMARY SCLEROSING CHOLANGITIS; AUTOIMMUNE CHOLANGITIS; PREVALENCE; HEPATITIS; PATIENT;
D O I
10.1016/S1665-2681(19)31016-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Liver involvement in celiac disease (CD) varies from asymptomatic mild non-specific hepatitis to liver failure. Here we report the first child with liver failure due to a sclerosing cholangitis associated with CD. Case report. An 11 year old girl presented with fatigability for 1 year and jaundice and abdominal distension for 3 weeks. On examination, the growth parameters were below 3rd percentile; she had splenomegaly and severe ascites. Liver function tests revealed elevated liver enzymes (ALT 84 U/L, total bilirubin 98.7 mu mol/L, and direct 58.3 mu mol/L, gamma-glutamyltransferase 111 U/L, INR 2.7, and albumin 16 g/L). Extensive investigations excluded infectious, metabolic, structural, and endocrine causes of chronic liver disease. Because of the short stature and anemia, CD was suspected, and serological evaluation revealed increased IgA antibodies to tissue transglutaminase (385 units; normal, 0-20 units). Histopathological examination of small intestinal biopsies showed total villous atrophy consistent with celiac disease. Liver biopsy showed bridging fibrosis, portal tract expansion by lymphocytes, plasma cells, and neutrophils, bile ductular proliferation, and periductular fibrosis. Magnetic resonance cholangiography revealed beading and narrowing appearance of intra- and extrahepatic bile ducts. The histopathological and imaging findings are diagnostic of sclerosing cholangitis. The child was initiated on ursodeoxycholic acid, gluten free diet for life, and steroid that was tapered over 3 months. At 3 month follow up, liver function tests completely normalized. Conclusion. CD is a potentially treatable cause of liver failure. All patients with severe unexplained liver disease should undergo serological screening for CD.
引用
收藏
页码:501 / 505
页数:5
相关论文
共 50 条
  • [11] Liver manifestation of patients with celiac disease: A single center experience
    Akinsanya, Adeyinka
    Gonzalez, Ivan A.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 71
  • [12] To screen or not to screen? Celiac antibodies in liver diseases
    Narciso-Schiavon, Janaina Luz
    Schiavon, Leonardo Lucca
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (05) : 776 - 791
  • [13] Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications
    Hoffmanova, Iva
    Sanchez, Daniel
    Tuckova, Ludmila
    Tlaskalova-Hogenova, Helena
    NUTRIENTS, 2018, 10 (07):
  • [14] Atypical erythema annulare centrifugum in a child with celiac disease
    Votto, Martina
    De Filippo, Maria
    Licari, Amelia
    Caimmi, Silvia
    Marseglia, Gian Luigi
    Davidovich, Shay
    Slawatyniec, Iga
    Fraticelli, Sara
    Barruscotti, Stefania
    Brazzelli, Valeria
    CLINICAL CASE REPORTS, 2021, 9 (07):
  • [15] Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders
    Valvano, Marco
    Longo, Salvatore
    Stefanelli, Gianpiero
    Frieri, Giuseppe
    Viscido, Angelo
    Latella, Giovanni
    NUTRIENTS, 2020, 12 (04)
  • [16] Celiac Disease
    Evans, Kate E.
    Sanders, David S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (03) : 639 - +
  • [17] Celiac Disease
    Murray, Joseph A.
    Frey, Mark R.
    Oliva-Hemker, Maria
    GASTROENTEROLOGY, 2018, 154 (08) : 2005 - 2008
  • [18] Celiac disease
    Malamut, G.
    Cellier, C.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 428 - 433
  • [19] Celiac disease
    Vauquelin, B.
    Riviere, P.
    REVUE DE MEDECINE INTERNE, 2023, 44 (10): : 539 - 545
  • [20] Celiac Disease
    Oxentenko, Amy S.
    Rubio-Tapia, Alberto
    MAYO CLINIC PROCEEDINGS, 2019, 94 (12) : 2556 - 2571